Literature DB >> 17051565

Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues.

Fredric Gordon1.   

Abstract

KEY CONCEPTS: 1. Primary sclerosing cholangitis (PSC) in the nontransplant setting is a chronic, progressive liver disease characterized by diffuse stricturing of the biliary tree, cholestatic liver enzymes, and a compatible liver biopsy. 2. Cholangiography reveals irregularity of the bile duct wall, strictures, beading, and diverticula. 3. The typical biopsy reveals inflammation and fibrosis of the interlobular and septal bile ducts, often with obliteration or biliary-type cirrhosis. 4. The precise pathogenetic mechanism remains elusive but is assumed to be an autoimmune phenomenon. 5. For patients with end-stage complications of PSC, such as liver failure, recurrent bacterial cholangitis, and intractable pruritus, liver transplantation is an acceptable treatment option. Copyright 2006 AASLD.

Entities:  

Mesh:

Year:  2006        PMID: 17051565     DOI: 10.1002/lt.20948

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

Review 1.  Controversies in the management of primary sclerosing cholangitis.

Authors:  Jeremy S Nayagam; Stephen P Pereira; John Devlin; Phillip M Harrison; Deepak Joshi
Journal:  World J Hepatol       Date:  2016-02-18

Review 2.  Endoscopic and surgical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-10-21

3.  Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience.

Authors:  Hiroto Egawa; Kaoru Taira; Satoshi Teramukai; Hironori Haga; Yoshihide Ueda; Atsushi Yonezawa; Satohiro Masuda; Hiroaki Tsuji; Eishi Ashihara; Yasutsugu Takada; Shinji Uemoto
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

Review 4.  Clinical features and management of primary sclerosing cholangitis.

Authors:  Marina-G Silveira; Keith-D Lindor
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

5.  Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.

Authors:  Fredric D Gordon; David S Goldberg; Nathan P Goodrich; Anna S F Lok; Elizabeth C Verna; Nazia Selzner; R Todd Stravitz; Robert M Merion
Journal:  Liver Transpl       Date:  2016-08-02       Impact factor: 5.799

Review 6.  Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects.

Authors:  Evangelos Cholongitas; Andrew K Burroughs
Journal:  Auto Immun Highlights       Date:  2012-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.